Officials and experts at the workshop.
THE PENINSULA
Doha, Qatar: Hamad Medical Corporation (HMC), in collaboration with Johnson & Johnson Institute, achieved another milestone in healthcare leadership by successfully hosting the first comprehensive Oncoplastic Breast Surgery Workshop in the region, recently.
This landmark initiative highlighted HMC’s commitment in advancing healthcare and education in the region, establishing Qatar as a hub for clinical excellence and professional training in alignment with Qatar National Vision 2030, which calls for a skilled healthcare workforce.
Oncoplastic breast surgery, which combines oncologic and plastic surgical techniques to achieve optimal cancer control and aesthetic outcomes, is now considered the global gold standard in breast cancer treatment. This workshop also marked HMC’s success in establishing the region’s first specialized Oncoplastic Breast Surgery Unit and dedicated Oncoplastic Multidisciplinary Team (MDT).
“This was the first initiative of its kind in the region, and we are proud to position Qatar as a regional center of excellence for oncoplastic education,” said Dr. Artefaa Alshamari, Consultant Oncoplastic Breast Surgeon and Clinical Lead of the Breast Surgery Unit at HMC.
